ETF Opportunities Trust has released its latest quarterly filing, providing important insights into its financial status. The filing, dated October 29, 2026, shows that the firm has total assets amounting to approximately $99.56 million and net assets of about $33.85 million.
This report is significant as it reflects the ongoing trends in the investment industry, especially in asset management and fund performance. Investors and analysts will likely scrutinize these figures to gauge the company's health and its competitiveness in the market.
Background
ETF Opportunities Trust is an investment firm incorporated in Delaware. The company primarily operates in the investment sector, focusing on managing various funds. Its recent filings include several forms submitted on October 29, 2026, including multiple NPORT-P forms.
What the Filing Says
The filing indicates that as of August 31, 2026, the total assets of ETF Opportunities Trust were reported at $99,556,909.65, with total liabilities of $65,709,442.71. This results in net assets of $33,847,466.94.
"The total net assets reflect the ongoing performance of our funds and our commitment to managing investor interests effectively," said Karen Shupe, Treasurer of ETF Opportunities Trust.
Impact
This update may affect various stakeholders, including current and potential investors, analysts, and competitors within the investment industry. The reported figures provide a benchmark for evaluating ETF Opportunities Trust's performance against its peers.
What's Next
The filing does not specify what happens next for ETF Opportunities Trust. However, it is likely that further updates will follow as the company continues to manage its investment strategies and respond to market conditions.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






